NantCell, Inc and Immunotherapy NANTibody, LLC v Sorrento Therapeutics, Inc. et al.

Quinn Emanuel Urquhart & Sullivan won a $173.5 million arbitration award for NantCell, Inc., a wholly-owned subsidiary of ImmunityBio, Inc., and Immunotherapy NANTibody, LLC.The award was…

This content is for Standard 1 Year members only.
Login Join Now

International Seaways’ Nomination of New Indipendent Directors

Kumquat Biosciences’ $1.2 Billion Collaboration and License Agreement with Takeda

23andMe Holding Co.’s Take Private Transaction

MK Properties’ Acquisition of Cyrela Rosa Empreendimentos Imobiliarios

Atem’s Distribuidora de Petroleo’s R$100 Million Debentures Issuance

Inverfal’s Debt Securities Program

GLP’s Acquisition of a Logistics Property in Philippsburg

Ocean Technologies Group’s Acquisition of DanDocs

ETZ Hospital Group’s €115m Financing

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

SIX Group’s Acquisition of a Majority Stake in FactEntry

Z3Partners’ Acquisition of Minority Stake in Wow Momos Foods

Collective Newsroom Private Limited’s Restructuring of India operations of BBC

Paul Hastings Adds Premier Private Equity Buyout Team

BCLP Appoints Trevor Varnes as Chief Financial Officer

B&C Tax strengthens its practice with new partner Daniela Diciaula

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Paul Hastings Adds Premier Private Equity Buyout Team

BCLP Appoints Trevor Varnes as Chief Financial Officer

B&C Tax strengthens its practice with new partner Daniela Diciaula

NantCell, Inc and Immunotherapy NANTibody, LLC v Sorrento Therapeutics, Inc. et al.

Author: Sonia Carcano